Preventing the flu: Researchers looking for a new approach

gtmrick
June 5, 2015
Uncategorized

Lifetime: New approach to fighting influenza Advertise on CTVNews.ca

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

Close Menu

You Might Also Like

Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

The COVID-19 Coronavirus Leads to Acute Respiratory Distress Syndrome (ARDS)

About

Vasomune Therapeutics 2019 © All Rights Reserved.